EJMK Ventures’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
EJMK Ventures's NVS Position: Q3 2026 in Review
EJMK Ventures reduced its Novartis (NVS) stake by 0.46% in Q3 2026, selling an estimated $1.36K and leaving 1,939 shares worth $276K. The position accounts for 0.12% of the portfolio, ranked #132.
EJMK Ventures first reported a position in NVS in Q2 2026 and has held it in 2 quarters since. The position peaked at $305K in Q2 2026. 1,557 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- EJMK Ventures held 1,939 shares of Novartis worth $276K as of Q3 2026.
- EJMK Ventures sold 9 Novartis shares in Q3 2026, an estimated $1.36K.
- Novartis made up 0.12% of EJMK Ventures's portfolio in Q3 2026, its #132 holding.
- EJMK Ventures first reported a position in Novartis in Q2 2026 and has held it in 2 quarters since.
- EJMK Ventures's Novartis position peaked at $305K in Q2 2026.
- 1,557 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on EJMK Ventures's 13F filing for Q3 2026, filed 21 Oct 2026.